Pharmacology, Toxicology and Pharmaceutical Science
Heart Infarction
100%
Nonalcoholic Fatty Liver
71%
Fatty Liver
67%
Cardiovascular Disease
66%
All Cause Mortality
47%
Prevalence
33%
Uric Acid
29%
Kidney Disease
29%
Liver Disease
29%
Coronary Artery Disease
29%
Ischemic Heart Disease
29%
Diseases
29%
Chronic Kidney Failure
14%
Cardiovascular Mortality
14%
Genetic Risk
13%
Fatty Acid
8%
Artery Disease
7%
Cardiovascular Agent
7%
Health Status
7%
Genetic Predisposition
5%
Medicine and Dentistry
Cardiovascular Disease
58%
Kidney Function
47%
Genetic Risk
43%
Diet Quality
42%
Myocardial Infarction
40%
Cardiovascular System
33%
Healthy Diet
30%
Glomerular Filtration Rate
29%
Nephropathy
29%
Body Mass Index
29%
Ischemic Heart Disease
29%
Nutrition
29%
Chronic Kidney Disease
24%
Fatty Liver
20%
Coronary Artery Disease
16%
All Cause Mortality
16%
Prevalence
16%
Physical Activity
12%
Cardiovascular Mortality
8%
Diabetes
6%
Proportional Hazards Model
6%
Combination Therapy
5%
Healthy Eating
5%
Patient with Cardiovascular Condition
5%
Disease
5%
Genetic Predisposition
5%
Biochemistry, Genetics and Molecular Biology
Prevalence
44%
Waist Circumference
34%
Systolic Blood Pressure
29%
Body Mass
29%
Genetics
29%
Lipogenesis
29%
Genetic Risk
24%
Glomerulus Filtration
24%
Single-Nucleotide Polymorphism
19%
Genomics
19%
All Cause Mortality
16%
Kidney Function
14%
Physical Activity
12%
Quantitative Trait Locus
9%
Genotyping
9%
Minor Allele Frequency
9%
Expression Quantitative Trait Loci
9%
DNA Methylation
9%
Blood Pressure
9%
Genetic Predisposition
9%
Fatty Acid Synthesis
9%
Lipid
9%
Cardiovascular Mortality
8%